sunesis pharmaceuticals inc
(SNSS:NASDAQ CM)
Executive Profile*
Daniel N. Swisher Jr.Chief Executive Officer, President and Director, Sunesis Pharmaceuticals, Inc. |
| Age | Total Calculated Compensation | This person is connected to 20 board members in 2 different organizations across 3 different industries. See Board Relationships |
| 48 | $1,174,222 As of Fiscal Year 2012 |
Background*
Mr. Daniel N. Swisher, Jr., Dan has been Chief Executive Officer of Sunesis Pharmaceuticals Inc., since January 2004 and as its President since August 2005. Mr. Swisher joined Sunesis Pharmaceuticals in January 2002 and served as its Chief Business Officer & Chief Financial Officer from December 2001 to December 2003. Mr. Swisher served as Chief Operating Officer of Sunesis. He has more than 15 years of experience in pharmaceutical product development, commercialization ...
Corporate Headquarters*395 Oyster Point BoulevardSouth San Francisco, California 94080 United States Phone: 650-266-3500 Fax: 650-266-3501 Board Members Memberships*2004-Present Chief Executive Officer, President and Director 2011-Present Director, Member of Audit Committee and Member of Nominating & Corporate Governance Committee
Education*BA Yale University MBA Stanford Graduate School of Business
Other Affiliations* |
Annual Compensation*
Stock Options*
Total Compensation*
|
| Recently Viewed | |||
| SNSS:US | $5.55 USD | +0.09 |  |
COMPETITOR COMPENSATION
| Name | Position/ Company | Compensation |
| Robert W. Cook | Interim Chief Executive Officer, Interim President, Chief Financial Officer, Principal Accounting Officer, Senior Vice President of Finance & Administration, Secretary and Director EpiCept Corporation | $326.2K |
| John R. Plachetka Pharm D. | Co-Founder, Chairman of the Board, Chief Executive Officer and President POZEN Inc. | $574.5K |
| Ronald A. Martell | Chief Executive Officer, President and Director NeurogesX, Inc. | -- |
| Mark A. Sirgo Pharm.D. | Chief Executive Officer, President, Chief Scientific Officer, Executive Director, Member of Executive Subcommittee and Member of Risk Management Committee BioDelivery Sciences International, Inc. | $620.5K | Compensation as of Fiscal Year 2012. |
Post a JobJobs
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
- Thornton, CO | IntuitPosted: Apr 29
Sponsored Financial Commentaries
Sponsored Links
To contact SUNESIS PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
